ADMA Biologics Announces Poster Presentation at IDWeek 2019

NEXT STORY
SIGA Completes Clinical Studies for IV Formulation of TPOXX®, NDA to be Submitted in 2020   
PREV STORY
Calithera Biosciences Completes Patient Enrollment in Randomized CANTATA Trial of Telaglenastat and Cabozantinib in Advanced Renal Cell Carcinoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Iterum Therapeutics Announces Filing of US Patent Application Based on Favorable Written Opinion of the International Search Authority

author_avatar
NASDAQ Market News

Nabriva Therapeutics and Roivant Sciences Enter into License Agreement to Develop and Commercialize Lefamulin in Greater China

DUBLIN, Ireland and HONG KONG, March 27, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), ...

author_avatar
NASDAQ Market News

Skylight Health Announces Closing of Florida Clinic with 2020 Performance of $6MM in Revenue and $1.35MM in EBITDA

author_avatar
NASDAQ Market News